JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY)

• Articles • Previous Articles     Next Articles

Treatment of allergic rhinitis by nebulized interferon gamma

LI Qin1, DU Ying-hua1, CHEN Yan-lin1, LIU Yu-gang2, ZHANG Da-liang3   

  1. 1. Department of Otorhinolaryngology, Linyi People′s Hospital, Linyi 276003;2. Department of Immunology, School of Medicine, Shandong University, Jinan 250012;3. Department of Otolaryngology & Head and Neck Surgery
  • Received:1900-01-01 Revised:1900-01-01 Online:2007-02-24 Published:2007-02-24
  • Contact: LI Qin

Abstract: Objective: To investigate the efficacy and mechanism of nebulized interferon gamma (IFN-r) in the prevention and treatment of allergic rhinitis. Methods: Ovalbumirl (OVA) absorbed to aluminum hydroxide was used to construct the allergic rhinitis model (group C), and nebulized IFN-r 12ug was inhaled once daily on day 23 to day 30. The nasal lavage fluid was collected on day 31, and the cellular constituents, levels of IL-4, IL-5 and IgE were determined. The normal control group (group A), the allergic rhinitic model group (group B) and beclomethasone dipropionate group (group D) consisted of five mice each. Results: Decrease of eosinophils (0.005±0.003)×104/ml was seen in nasal lavage fluid of group C as compared with group B[(0.223±0.068)×104/ml,(P<0.01)], and the levels of IL-4(7.8±3.2pg/mL) and IL-5(12.5±4.6pg/mL) decreased significantly in comparison with group B(P<0.01). The serum levels of total IgE (38.5±9.6ug/ml) and ovalbuminspecific IgE(19.6±5.2U/mL )decreased significantly in comparison with those of group B(P<0.01). Conclusion: IFN-r can inhibit the composition of IL-4 and IL-5, and inhibit the airway inflammation with eosinophilic infiltration and the serum levels of total IgE and ovalbumin specific IgE, and so it is helpful in prevention and treatment of allergic rhinitis.

Key words: Allergic rhinitis, Interferon gamma, Nebulized, Treatment outcome

CLC Number: 

  • R765.21
[1] LYU Qian, TANG Yuan, GU Zijun, SHI Sailei, LIU Ping, WAN Wenjin. Current status of benefit finding among patients with allergic rhinitis and its influence factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 21-28.
[2] GU Min, LU Meiping. Advances in the application of nanomedicine delivery systems in allergen immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 106-111.
[3] QIN Nana, LI Yufen, SUN Yuhao, WEI Jian, LI Qin. Effect of interleukin-13 receptor-α2 on nasal mucosal remodeling in rats with allergic rhinitis by TGF-β1/Smad signaling pathway [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 71-77.
[4] DU Kangli, ZHENG Zhenyu, XU Zhanjiang, ZHANG Yu, CHEN Lu, LU Mengyao. Construction and validation of risk prediction model for nasal septal deviation complicated with chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 78-86.
[5] XIONG Qin, ZHANG Yan, WU Rina, LI Feng, TANG Lixing. Application of intranasal corticosteroids in pediatrics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 160-167.
[6] XU Xuemeng, FAN Lei, YU Wangbo, JIANG Zhiyue, PAN Chen, HUANG Yongqin. Meta-analysis of the efficacy of omalizumab in combination with specific immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 26-33.
[7] HUANG Huan, HUA Hongli, DENG Yuqin, JIANG Chengyang, WANG Yuwei, YANG Xinghai. Correlation of allergic rhinitis, tonsil adenoid hypertrophy, and sinusitis in children and analysis of its clinical guiding value [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 34-41.
[8] LIU Yijun, GU Yue, GUAN Dayu, YANG Yucheng, SHEN Yang. The long-term clinical efficacy and safety of vidian neurectomy in refractory allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 42-48.
[9] ZHANG Ting, WANG Meilan, GAO Yingqin. Research progress of IL-35 in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 139-147.
[10] ZHANG Zhuping, PENG Zican, XIAO Zhenlong, LI Cheng, YU Di, WANG Xinglong, CHEN Wei, Guo Bei. The value of a novel nasal secretion eosinophil cationic protein-myeloperoxidase test paper assay in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 129-134.
[11] LIU Chang, YANG Jingpu, GAO Yu, WANG Wenjia. Analysis of allergen detection results in children with allergic rhinitis in the Changchun area [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 51-58.
[12] ZHOU Heqing, SHEN Qi. Research progress on biomarkers of traditional Chinese medicine in the treatment of allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 168-176.
[13] WANG Manxian, ZHENG Quan, YANG Liang. Research progress in the treatment of allergic rhinitis with bacterial lysates [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 141-145.
[14] LIU Chang, FANG Hongyan, LIU Xiao, FU Dongna, WANG He, WANG Jing, YANG Jingpu. Analysis of sensitization characteristics of Artemisia pollen in autumn allergic rhinitis in the Changchun area of China [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 13-19.
[15] WANG Zhenxiao, SHI Guanggang, HE Mingqiang, SHI Lei. Treatment options and management strategies for patients with acute laryngotracheobronchitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 136-144.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!